Every pharma CIO in India is being asked the same thing by their board: how much AI are we actually running — and can we defend it in an inspection? There is no credible room yet in which that question gets answered honestly.
This Congress is that room. 130+ senior pharma IT leaders. One room. No trade show noise. Just CIOs, CDOs, and practitioners making real decisions — with the vendors who earned their seat at the table.
Seven regulations land in the next 12 months. The industry needs a room where the tough questions — validation, accountability, documentation — get answered by expert practitioners, not consultants.
Minimum 60% pharma end-users. No open registration. Every delegate is a decision-maker — CIO, CDO, VP Digital, or practitioner. Vendors don't present to a crowd. They sit across the table from the people signing the POs.
09:00–18:30 at a 5-star Mumbai venue. A keynote arc that builds from strategy to execution. Four closed CXO roundtables. Three practitioner case studies. An evening reception where the real conversations start — and sponsor relationships are made.
Sun Pharma. Cipla. Lupin. Alkem. Piramal. Glenmark. Wockhardt. Abbott India. Pfizer India. Sanofi India.
Their IT and data leadership doesn't need to fly in. They're already here.
No other city in India concentrates this many pharma decision-makers in a single corridor — which means your one day of sponsorship activation reaches an audience it would take months of travel to replicate.
We chose Goregaon East because every major pharma HQ is within a 30-minute drive.
See the venue →Language and structure to bring back to your leadership team. Built from peer dialogue — not analyst reports.
What India's top 15 pharma CIOs are actually doing with AI. Candid. Unfiltered. Chatham House.
A practical GAMP AI Guide readiness checklist. Know exactly what inspectors will ask — before they ask it.
Every session ends with one actionable idea. Leave with a prioritised action list — not just inspiration.
“Who owns data in a decentralised pharma enterprise — and what happens to regulatory traceability?”
— Data Governance panel · 11:00